New insights on poly(vinyl acetate)-based coated floating tablets: Characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 2, 2008, Pages 708-717

  Strübing, Sandra ^a   Abboud, Tâmara ^a   Contri, Renata Vidor ^a   Metz, Hendrik ^a   Mäder, Karsten ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Coated tablets; Floating tablets; Kollicoat IR; Kollicoat SR; Kollidon SR; MRI; Poly(vinyl acetate)

Indexed keywords

CARBON DIOXIDE; KOLLICOAT IR; KOLLICOAT SR 30 D; KOLLIDON SR; POLYVINYL ACETATE; POVIDONE; PROPRANOLOL; TALC; TITANIUM DIOXIDE; TRIACETIN;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SAFETY; HYDRATION; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; SAMPLE; TABLET COMPRESSION; TABLET FORMULATION; TABLET MACHINE; TIME;

CARBON DIOXIDE; CHEMISTRY, PHYSICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; FOOD-DRUG INTERACTIONS; MAGNETIC RESONANCE IMAGING; POLYVINYLS; PROPRANOLOL; STOMACH; TABLETS; VISCOSITY; WATER;

EID: 43249119862     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.12.009     Document Type: Article

References (25)

1. Rouge N., Buri P., and Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 136 (1996) 116-122
2. Drewe J., Beglinger C., and Kissel T. The absorption site of cyclosporin in the human GIT. Br. J. Clin. Pharmacol. 33 (1992) 39-43
3. Harder S., Fuhr U., and Bergmann D. Ciprofloxacin absorption in different regions of the human GIT. Investigations with hf capsule. Br. J. Clin. Pharmacol. 30 (1990) 35-39
4. Klausner E.A., Lavy E., Stepensky D., Cserepes E., Barta M., Friedman M., and Hoffman A. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration in healthy volunteers. J. Clin. Pharmacol. 43 (2003) 711-720
5. Chen G.L., and Hao W.H. In vitro performance of floating sustained-release capsule of verapamil. Drug Dev. Ind. Pharm. 24 (1998) 1067-1072
6. Elkheshen S.A., Yassin A.E., Alsuwayeh S., and Alkhaled F.A. In vitro and in vivo evaluation of floatin controlled release dosage forms of verapamil hydrochloride. Pharm. Ind. 66 (2004) 1364-1372
7. Singh Matharu R., and Sanghavi N.M. Novel drug delivery systems for captopril. Drug Dev. Ind. Pharm. 18 (1992) 1567-1574
8. Whitehead L., Collett J.H., and Fell J.T. Amoxycillin release from a floating dosage form based on alginates. Int. J. Pharm. 210 (2000) 45-49
9. Oth M., Franz M., Timmermans J., and Moës A. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9 (1992) 298-302
10. Streubel A., Siepmann J., and Bodmeier R. Gastroretentive drug delivery systems. Expert Opin. Drug Deliv. 3 2 (2006) 217-233
11. Lee J.W., Park J.H., and Robinson J.R. Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 89 (2000) 850-866
12. Deshpande A.A., Shah N.H., Rhodes C.T., and Malick W. Development of a novel controlled-release system for gastric retention. Pharm. Res. 14 (1997) 815-819
13. Klausner E.A., Lavy E., Friedman M., and Hoffman A. Expandable gastroretentive dosage forms. J. Control. Release 90 (2003) 143-162
14. Desai S., and Bolton S. A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm. Res. 10 (1993) 1321-1325
15. Strübing S., Metz H., and Mäder K. Characterization of polyvinyl acetate based floating matrix tablets. J. Control. Release. (2007) 10.1016/j.jconrel.2007.11.013
16. Draganoiu E., Andheria M., and Sakr A. Evaluation of new polyvinylacetate/povidone excipient for matrix sustained release dosage forms. Pharm. Ind. 63 (2002) 624-629
17. Sawicki W., and Lunio R. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D. Eur. J. Pharm. Biopharm. 60 (2005) 153-158
18. Baille W.E., Malveau C., Zhu X.X., and Marchessault R.H. NMR imaging of high-amylose starch tablets. 1. Swelling and water uptake. Biomacromolecules 3 (2002) 214-218
19. Malveau C., Baille W.E., Zhu X.X., and Marchessault R.H. NMR imaging of high-amylose starch tablets. 2. Effect of tablet size. Biomacromolecules 3 (2002) 1249-1254
20. Thérien-Aubin H., Baille W.E., Zhu X.X., and Marchessault R.H. NMR imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects. Biomacromolecules 6 (2005) 3367-3372
21. Fukuda M., Peppas N.A., and McGinity J.W. Floating hot-melt extruded tablets for gastroretentive controlled drug release system. Pharm. Res. 115 (2006) 121-129
22. Timmermans J., and Moës A.J. How well do floating dosage forms float?. Int. J. Pharm. 62 (1990) 207-216
23. J. Timmermans, A.J Moës, Apparatus and method for resultant-weight measuring system. US Patent 5,076,107, 1991.
24. Strübing S., Metz H., and Mäder K. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery. Eur. J. Pharm. Biopharm. 66 1 (2007) 113-119
25. 1H NMR spectroscopy and SEM. J. Control. Release 119 2 (2007) 190-196